Search

Scott T. Tagawa

Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer
Functional Characterization of Circulating Tumor Cells with a Prostate-Cancer-Specific Microfluidic Device
Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody

Published with Wowchemy — the free, open source website builder that empowers creators.